Albumin Market Analysis

Source Segment Analysis

The plasma-derived subsegment is expected to hold the largest market share of 58% within the forecast period in the source segment in the albumin market, due to its established production infrastructure and cost-effectiveness. Plasma-derived albumin is used widely in treating therapies for volume expansion and burns. According to the American Liver Foundation in September 2023, over 51,642 adults died of liver disease in the U.S. many need plasma-derived albumin for proper treatment and fluid resuscitation. As recombinant albumin advances, preference is for plasma-derived recombinant albumin to be available on such a scale. The establishment of new plasma fractionation centers, especially in new markets, further fortifies the supply capacity and secures the segment's dominance until 2035.

Type Segment Analysis

The human serum albumin segment is projected to garner the highest revenue share in the type segment of the market, owing to its extensive use in clinical settings and the management of critical illnesses and chronic conditions. The product is mainly used for treating hypoalbuminemia, especially in liver and kidney-related complications. According to the American Liver Foundation in September 2023, over 100 million people in America are affected by some form of liver disease as of September 2023, and most of these could benefit from albumin therapy. While the safety and therapeutic efficacy of HSA establish it as a winner against recombinant albumin, the rising incidence of chronic diseases all over the world further promotes the sustenance of demand for HSA in the near future.

Distribution Segment Analysis

The hospital pharmacies sub-segment is expected to hold the highest market share within the forecast period in the distribution segment, primarily as hospitals are the place where care of such patients under albumin therapy is provided. Simply put, a hospital pharmacy brings essential critical care products  such as serum albumin, right to the patients, so it can be used either for emergency or ongoing treatments. The World Health Organization (WHO) reported in October 2023 that more than 410,000 burn injuries were registered in the U.S., out of which about 40,000 were severe enough to require hospitalization. Thus, the surging hospital admissions caused by chronic ailments and trauma cases across the globe promote the growing demand for this sub-segment. In addition, hospital pharmacies get a boost from the developing healthcare infrastructure in developing countries.

Our in-depth analysis of the market includes the following segments: